Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb)
CA 2378032 A1 · Owner: Benson, Timothy E. · Inventors: Benson, Timothy E.; Harris, Melissa S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The substrate free form of Staphylococcus aureus UDP-Nacetylenolpyruvylglucosamine reductase S. ureus MurB has been crystallized and the three dimensional x-ray crystal structure has been solved to 2.3 .ANG. resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes and designing inhibitors of S. aureus MurB.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 4, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 4, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 4, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.